Who is sponsoring NCT03382366?

NCT03382366 is sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio.

What drugs are being tested in NCT03382366?

Interventions in NCT03382366: Blood sampling, risk of fall evaluation, and MR acquisition..

What condition does NCT03382366 study?

NCT03382366 studies Sarcopenia, Falls Patient, Osteoporosis, Postmenopausal.

Is NCT03382366 still recruiting?

NCT03382366 is currently status unknown. Last updated 17 July 2018.

Last reviewed 2018-07-17 · How we verify

NCT03382366: Sarcopenia

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sarcopenia and Risk of Fall in Osteoporotic Postmenopausal Women

Status unknown NA Last updated 17 July 2018

What this trial tests

NA trial testing Blood sampling, risk of fall evaluation, and MR acquisition. in Sarcopenia in 40 participants. Status unknown.

Timeline

29 March 2017

Primary endpoint
31 May 2019

31 May 2019

Quick facts

Lead sponsor	I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	40
Start date	29 March 2017
Primary completion	31 May 2019
Estimated completion	31 May 2019
Sites	1 location across Italy

Drugs / interventions tested

Blood sampling, risk of fall evaluation, and MR acquisition.

Conditions studied

Sarcopenia — all drugs for Sarcopenia →
Falls Patient — all drugs for Falls Patient →
Osteoporosis, Postmenopausal — all drugs for Osteoporosis, Postmenopausal →

Sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio — full company profile →

Who can join

60 and older, female only, with Sarcopenia or Falls Patient. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main scope of the present pilot study is to evaluate the possible association between the status of sarcopenia and the risk of fall in osteoporotic postmenopausal women. Forty osteoporotic postmenopausal women, previously (pre-recruitment) classified by DXA in 20 sarcopenic and 20 non-sarcopenic subjects, will be recruited. The investigators will collect data on: 1) bone (vitamin D) and muscle (myokines) metabolisms through blood sampling; 2) Risk of fall by the OAK device produced by Khymeia; 3) thigh muscle quality through MR.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Circulating Carboxylated Osteocalcin Correlates With Skeletal Muscle Mass and Risk of Fall in Postmenopausal Osteoporotic Women.
Vitale JA, Sansoni V, Faraldi M, Messina C, et al · · 2021 · cited 22× · PMID 34025583 · DOI 10.3389/fendo.2021.669704
Plasma microRNA signature associated with skeletal muscle wasting in post-menopausal osteoporotic women.
Faraldi M, Sansoni V, Vitale J, Perego S, et al · · 2024 · cited 19× · PMID 38272849 · DOI 10.1002/jcsm.13421

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

NCT07500376 — Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery · recruiting
NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
NCT07398495 — Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia · NA · recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT07426159 — AI-Guided Sarcopenia Risk Assessment and Detection · NA · active not recruiting

Other I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio trials

Trials by the same sponsor.

NCT07386405 — Validation and Cultural Adaptation of the KOOS-ACL Scale for the Italian Population · not yet recruiting
NCT07352111 — High-risk Coronary Atherosclerosis in Subjects With Family History of Myocardial Infarction · NA · recruiting
NCT07304323 — Prepare II - Predictive Model Training and External Validation · recruiting
NCT07337499 — Comparison of Maglumi X3 SNIBE With Other Analytical Methods in Laboratory Medicine for 25-(OH)D Quantification · recruiting
NCT06940245 — Use of Virtual Reality for the Assessment of Attentional and Reaction Abilities for Fall Risk Evaluation · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03382366 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Last refreshed: 17 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03382366.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing